Paper39635531
Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease.
Gotelli E and 13 others. Front Immunol, 2024. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease. Papers, record 39635531. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39635531
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevalence of hybrid TLR4+M2 monocytes/macrophages in peripheral blood and lung of systemic sclerosis patients with interstitial lung disease.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Scleroderma, Systemic | Major topic |
| Toll-Like Receptor 4 | Major topic |
| Lung Diseases, Interstitial | Major topic |
| Monocytes | Major topic |
| Macrophages | Major topic |
| Humans | |
| Middle Aged | |
| Female | |
| Male | |
| Adult | |
| Aged | |
| Lung | |
| Biomarkers | |
| Macrophages, Alveolar |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31046487 | Pathophysiology of systemic sclerosis: current understanding and new insights. | Expert Rev Clin Immunol | 2019 | https://conductscience.org/library/papers/31046487 | PubMed |
| 2 | 37490353 | Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis. | Curr Opin Rheumatol | 2023 | https://conductscience.org/library/papers/37490353 | PubMed |
| 3 | 27311059 | CD1c-Expression by Monocytes - Implications for the Use of Commercial CD1c+ Dendritic Cell Isolation Kits. | PLoS One | 2016 | https://conductscience.org/library/papers/27311059 | PubMed |
| 4 | 37833928 | Involvement of Epithelial-Mesenchymal Transition (EMT) in Autoimmune Diseases. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37833928 | PubMed |
| 5 | 32663627 | May capillaroscopy be a candidate tool in future algorithms for SSC-ILD: Are we looking for the holy grail? A systematic review. | Autoimmun Rev | 2020 | https://conductscience.org/library/papers/32663627 | PubMed |
| 6 | 20602758 | Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis. | Arthritis Res Ther | 2010 | https://conductscience.org/library/papers/20602758 | PubMed |
| 7 | 25619868 | Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. | Cytometry B Clin Cytom | 2016 | https://conductscience.org/library/papers/25619868 | PubMed |
| 8 | 38509595 | Nintedanib downregulates the profibrotic M2 phenotype in cultured monocyte-derived macrophages obtained from systemic sclerosis patients affected by interstitial lung disease. | Arthritis Res Ther | 2024 | https://conductscience.org/library/papers/38509595 | PubMed |
| 9 | 34741001 | Is There a Link Between Nailfold Videocapillaroscopy and Pulmonary Function Tests in Systemic Sclerosis Patients?: A 24-Month Follow-up Monocentric Study. | J Clin Rheumatol | 2022 | https://conductscience.org/library/papers/34741001 | PubMed |
| 10 | 38996486 | Immune mechanisms in fibrotic interstitial lung disease. | Cell | 2024 | https://conductscience.org/library/papers/38996486 | PubMed |
| 11 | 34910301 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). | Eur J Immunol | 2021 | https://conductscience.org/library/papers/34910301 | PubMed |
| 12 | 32113575 | Systemic sclerosis-associated interstitial lung disease. | Lancet Respir Med | 2020 | https://conductscience.org/library/papers/32113575 | PubMed |
| 13 | 35861385 | Macrophages as determinants and regulators of fibrosis in systemic sclerosis. | Rheumatology (Oxford) | 2023 | https://conductscience.org/library/papers/35861385 | PubMed |
| 14 | 34327818 | Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34327818 | PubMed |
| 15 | 20674506 | Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. | Clin Immunol | 2010 | https://conductscience.org/library/papers/20674506 | PubMed |
| 16 | 32448163 | Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways. | Mol Med | 2020 | https://conductscience.org/library/papers/32448163 | PubMed |
| 17 | 37382458 | Pharmacological treatment of systemic sclerosis-associated interstitial lung disease: an updated review and current approach to patient care. | Clin Exp Rheumatol | 2023 | https://conductscience.org/library/papers/37382458 | PubMed |
| 18 | 30181583 | Targeting the TLR4-MD2 axis in systemic sclerosis. | Nat Rev Rheumatol | 2018 | https://conductscience.org/library/papers/30181583 | PubMed |
| 19 | 23141927 | Toll-like receptor 4 signaling augments transforming growth factor-β responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. | Am J Pathol | 2013 | https://conductscience.org/library/papers/23141927 | PubMed |
| 20 | 34344444 | Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity. | Arthritis Res Ther | 2021 | https://conductscience.org/library/papers/34344444 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42846996 | LC3-associated phagocytosis is impaired in monocyte-derived macrophages from systemic sclerosis patients. | Autophagy Rep | 2026 | https://conductscience.org/library/papers/42846996 | PubMed |
| 42658262 | Macrophage programming in systemic sclerosis: Niches, networks, and translational horizons. | Semin Immunopathol | 2026 | https://conductscience.org/library/papers/42658262 | PubMed |
| 42353053 | Macrophage Plasticity: Phenotypic and Functional Profiles Across Pathological Microenvironments. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353053 | PubMed |
| 41553576 | The role of immune cell crosstalk and signaling pathways in the pathogenesis of pulmonary fibrosis. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/41553576 | PubMed |
| 41465549 | Immunopathogenic Mechanisms in Connective Tissue Disease-Associated Interstitial Lung Disease: Incessant Loop of Immunity to Fibrosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465549 | PubMed |
| 41381212 | Circulating monocytes from systemic sclerosis patients with progressive interstitial lung disease preferentially express M2 phenotype markers: in vitro and ex vivo study. | RMD Open | 2025 | https://conductscience.org/library/papers/41381212 | PubMed |
| 41316172 | Variable steady inflammation and inflammatory responses in precision-cut lung slices from various IPF lung Regions. | Respir Res | 2025 | https://conductscience.org/library/papers/41316172 | PubMed |
| 41140668 | Identification of routine blood derived hematological and lipid indices in ILD through machine learning; a retrospective case-control study. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41140668 | PubMed |
| 40721670 | Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases. | Nat Rev Rheumatol | 2025 | https://conductscience.org/library/papers/40721670 | PubMed |
| 40076729 | The Multifaceted Role of Macrophages in Biology and Diseases. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076729 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD14 | 929 | PubTator's text mining | https://conductscience.org/library/genes/929 | NCBI Gene |
| CD163 | 9332 | PubTator's text mining | https://conductscience.org/library/genes/9332 | NCBI Gene |
| CD1C | 911 | PubTator's text mining | https://conductscience.org/library/genes/911 | NCBI Gene |
| CD68 | 968 | PubTator's text mining | https://conductscience.org/library/genes/968 | NCBI Gene |
| CD80 | 941 | PubTator's text mining | https://conductscience.org/library/genes/941 | NCBI Gene |
| CD86 | 942 | PubTator's text mining | https://conductscience.org/library/genes/942 | NCBI Gene |
| FCGR3A | 2214 | PubTator's text mining | https://conductscience.org/library/genes/2214 | NCBI Gene |
| MRC1 | 4360 | PubTator's text mining | https://conductscience.org/library/genes/4360 | NCBI Gene |
| MSR1 | 4481 | PubTator's text mining | https://conductscience.org/library/genes/4481 | NCBI Gene |
| PTPRC | 5788 | PubTator's text mining | https://conductscience.org/library/genes/5788 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39635531
GET https://conductscience.org/api/papers/v1/39635531/references?page=2